Steve Gullans
When is "safe dosing" a dangerous prescription?
When is "safe dosing" a dangerous prescription?
Steve is an experienced investor, entrepreneur, writer, and scientist. At Excel Venture, he focuses on life science technology companies with a particular interest in disruptive platforms that can impact multiple industries. Steve was a faculty member at Harvard Medical School and Brigham and Women's Hospital for nearly 20 years.
Find out more